These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 34525243)
21. The association between the ICIQ-LUTS and the ICIQ-bladder diary in assessing LUTS. Abdelmoteleb H; Kamel MI; Hashim H Neurourol Urodyn; 2017 Aug; 36(6):1601-1606. PubMed ID: 27794164 [TBL] [Abstract][Full Text] [Related]
23. Reliability and validity of the overactive bladder symptom score in Hong Kong Chinese. Yiu MK; Li CM; Hou SM; Wong CW; Tam S; Chu SK Hong Kong Med J; 2013 Dec; 19(6):504-10. PubMed ID: 23787257 [TBL] [Abstract][Full Text] [Related]
24. Relationship between voided volume and the urge to void among patients with lower urinary tract symptoms. Blaivas JG; Tsui JF; Amirian M; Ranasinghe B; Weiss JP; Haukka J; Tikkinen KA Scand J Urol; 2014 Dec; 48(6):554-8. PubMed ID: 25029069 [TBL] [Abstract][Full Text] [Related]
25. Characterization of lower urinary tract symptoms in patients with idiopathic normal pressure hydrocephalus. Krzastek SC; Bruch WM; Robinson SP; Young HF; Klausner AP Neurourol Urodyn; 2017 Apr; 36(4):1167-1173. PubMed ID: 27490149 [TBL] [Abstract][Full Text] [Related]
26. Associations between subjective overactive bladder symptoms and objective parameters on bladder diary and filling cystometry. Daan NM; Schweitzer KJ; van der Vaart CH Int Urogynecol J; 2012 Nov; 23(11):1619-24. PubMed ID: 22543547 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of Sexual Dysfunction, Lower Urinary Tract Symptoms and Quality of Life in Men With Obstructive Sleep Apnea Syndrome and the Efficacy of Continuous Positive Airway Pressure Therapy. İrer B; Çelikhisar A; Çelikhisar H; Bozkurt O; Demir Ö Urology; 2018 Nov; 121():86-92. PubMed ID: 30118776 [TBL] [Abstract][Full Text] [Related]
28. Survey on prevalence of lower urinary tract symptoms in an Asian population. Yee CH; Chan CK; Teoh JYC; Chiu PKF; Wong JHM; Chan ESY; Hou SSM; Ng CF Hong Kong Med J; 2019 Feb; 25(1):13-20. PubMed ID: 30655460 [TBL] [Abstract][Full Text] [Related]
29. A questionnaire survey to assess lower urinary tract symptoms in patients with chronic stroke. Miyazato M; Tana T; Higa A; Wakugami K; Tokashiki T; Sakima H; Maehara A; Ashikari A; Oshiro T; Ohya Y; Saito S Neurourol Urodyn; 2017 Sep; 36(7):1890-1895. PubMed ID: 28169449 [TBL] [Abstract][Full Text] [Related]
34. Clinical features of supervoiders who suffer from lower urinary tract symptoms: a propensity score-matching study. Lee JY; Hah YS; Lee DH; Bang WJ; Ham WS; Lee SW; Cho KS World J Urol; 2013 Dec; 31(6):1463-8. PubMed ID: 23624717 [TBL] [Abstract][Full Text] [Related]
35. Effect of Voided Volume on Voiding Patterns and Reliability of Uroflowmetry-Electromyography Results in Children with Lower Urinary Tract Dysfunction. Dayanc MM; Kibar Y; Irkilata HC; Sancaktutar AA; Ebiloglu T; Gur A; Ergin G; Alp BF; Gok F Low Urin Tract Symptoms; 2017 Jan; 9(1):46-51. PubMed ID: 28120443 [TBL] [Abstract][Full Text] [Related]
36. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response. Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467 [TBL] [Abstract][Full Text] [Related]
37. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis? Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999 [TBL] [Abstract][Full Text] [Related]
38. Tolterodine treatment of women with overactive bladder syndrome: Comparison of night-time and daytime dosing for nocturia. Tsai KH; Hsiao SM; Lin HH J Obstet Gynaecol Res; 2017 Nov; 43(11):1719-1725. PubMed ID: 28714288 [TBL] [Abstract][Full Text] [Related]
39. Impact of transobturator tape treatment on overactive bladder symptoms, particularly nocturia, in patients with mixed urinary incontinence. Lee SK; Kang HW; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ Korean J Urol; 2014 Aug; 55(8):520-6. PubMed ID: 25132946 [TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine. Sebastianelli A; Russo GI; Kaplan SA; McVary KT; Moncada I; Gravas S; Chapple C; Morgia G; Serni S; Gacci M Int J Urol; 2018 Mar; 25(3):196-205. PubMed ID: 29205506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]